Implanet offers to buy majority stake in medtech company

Patsy Newitt -   Print  |

Boston-based medical technology company Implanet has received approval from its founding shareholders to acquire a majority stake in French implant manufacturer Orthopaedic & Spine Development, the company reported March 17. 

Implanet specializes in vertebral and knee surgery implants. OSD manufactures, develops and markets spinal implants. The acquisition aims to strengthen Implanet's position in the spine market, according to the company. 

OSD is valued at just over $5 million. OSD's founding shareholders, representing 71.5 percent of the capital, have responded favorably to the offer. A shareholder agreement to submit the acquisition will be convened before March 31.

More articles on physicians:
There were 226 ASCs opened in 2019 & 3 more MedPAC 2021 report highlights
ENT specialists join Florida physician group
Bundled payments in ASCs: Good business or a race to the bottom?

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers